Mechanochemical ablation for great and small saphenous veins insufficiency in patients with type III shunt

• Published in: Phlebology Vol. 36; no. 2; p. 145
• Main Authors: Mosquera-Rey, Vicente, Del Castro Madrazo, José A, Ángeles M Herrero, María, Cordeu, Rubén A, Azofra, Ernesto A, Pérez, Manuel A
• Format: Journal Article
• Language: English
• Published: England 01.03.2021
• Subjects: mechanochemical ablation; saphenous vein; chronic venous insufficiency; varicose veins; ClariVein
• ISSN: 1758-1125
• DOI: 10.1177/0268355520951695

the aim of this study was to assess the results of mechanochemical endovenous ablation either in the primary or recurrent saphenous vein insufficiency, including only patients with veno-venous shunt type III. retrospective analysis of a prospective study of patients with symptomatic chronic venous insufficiency who underwent ClariVein® technique. A total of 134 saphenous veins were included between August 2017 and August 2018. Follow-up was performed by Duplex ultrasound at 1, 6 and 12 months. Primary endpoints were technical and anatomical success. Secondary endpoints were the need for further treatment of varicose collateral veins by sclerotherapy, outcomes regarding recurrent insufficiency and clinical success. A total of 111 great saphenous veins and 23 small saphenous veins were treated with a technical success of 95.6%. The overall anatomical success rates at 1, 6 and 12 month were 96.2%, 88.8% and 84.4%, respectively, without differences between primary and recurrent insufficiency. Deferred sclerotherapy over varicose collaterals was carried out in 28% of the patients with anatomical success. Clinical improvement was achieved in 87.3%. MOCA technique has proven to be an effective technique, although additional treatment over varicose collaterals could be necessary in up to one-third. Atrophy of the saphenous vein and the lack of persistent varicose collateral veins during follow-up seem to be indicators of successful therapy.